Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Average Rating of “Buy” from Analysts
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have received a consensus recommendation of “Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, eleven have assigned a buy recommendation and two have given a strong buy recommendation […]
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have received a consensus recommendation of “Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, eleven have assigned a buy recommendation and two have given a strong buy recommendation […]
